Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Nasopharyngeal Carcinoma × Population Groups × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 1

Interventions

Cisplatin 49 Radiotherapy, Intensity-Modulated 26 Gemcitabine 26 Capecitabine 17 Docetaxel 16 toripalimab 11 Fluorouracil 11 Radiotherapy 9 Drug Therapy 8 nedaplatin 6 Induction Chemotherapy 5 spartalizumab 4 nimotuzumab 4 camrelizumab 4 Neoadjuvant Therapy 4 Carboplatin 4 tislelizumab 3 sintilimab 2 cisplatin-guanosine adduct 2 apatinib 2 SSRP1 protein, human 2 Immune Checkpoint Inhibitors 2 Endostatins 2 Chemoradiotherapy 2 CF regimen 2 streptococcal preparation 722 1 penpulimab 1 lobaplatin 1 endostar protein 1 Tegafur 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01536223 2013-03-05

ESNCCT

Zhejiang Cancer Hospital

Phase 3 Unknown

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡